Physician

Adam B Kaufman, MD

According to 2025 Medicare claims, Adam Kaufman, MD (NPI: 1568670198) practices gastroenterology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (NPI: 1154422806; TIN: 232812220) and primary practice location at 17601-2644. Kaufman is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019) and Delaware Valley ACO (ACO ID: A2024), participating under the MSSP model.

Kaufman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 499 traditional Medicare patients, billed 14,111 HCPCS/CPT codes, and received $272,590 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 678 prescription claims across 182 beneficiaries totaling $1,361,700 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 112 records totaling $6,169. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $162,129 and ending at $272,590. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $66,923 to $1,361,700. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	416	4,288	$162,129
2016	387	10,832	$261,346
2017	411	7,220	$191,914
2018	412	12,199	$382,980
2019	417	18,103	$333,689
2020	387	11,216	$392,305
2021	471	19,231	$501,044
2022	452	17,628	$316,681
2023	445	15,997	$248,561
2024	499	14,111	$272,590

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	114	520	$66,923
2016	139	576	$73,604
2017	154	641	$140,403
2018	216	810	$232,308
2019	210	745	$329,802
2020	170	717	$437,286
2021	163	661	$365,238
2022	173	664	$865,022
2023	164	627	$959,993
2024	182	678	$1,361,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	177	179	$212
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	53	54	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	103	146	$96
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	80	80	$84
45380	Biopsy of large bowel using a flexible endoscope	72	73	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	41	1,792	$1,107,351
Mesalamine	Mesalamine	66	3,572	$36,971
Mesalamine Er	Mesalamine	17	1,200	$6,163
Budesonide Ec	Budesonide	16	857	$5,468
Balsalazide Disodium	Balsalazide Disodium	15	1,350	$3,667

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	112	$6,169	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam B. Kaufman, MD?

Tedicare shows public-source Medicare data for Adam B. Kaufman, MD (NPI 1568670198), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam B. Kaufman, MD have ACO affiliation data?

Adam B. Kaufman, MD is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019) and Delaware Valley ACO (MSSP, ACO ID A2024).

What billing organization is linked to Adam B. Kaufman, MD?

Adam B. Kaufman, MD is linked to REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD. (billing NPI 1154422806) in the available physician profile data.

Does Adam B. Kaufman, MD have Open Payments data?

Adam B. Kaufman, MD has 112 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.